Key result
Complex PCI significantly increased the 3-year risk of MACCE (HR 1.21; 95% CI 1.01-1.44; P=0.035), and high platelet reactivity was associated with MACCE irrespective of procedural complexity.
Why the study?
Complex PCI and high platelet reactivity are risk factors for the high ischemic phenotype, but their relative prognostic importance remained uncertain.
Does high platelet reactivity affect the risk of MACCE differently according to procedural complexity in patients treated with drug-eluting stents?
Cohort (n=11,714)
Does high platelet reactivity affect the risk of MACCE differently according to procedural complexity in patients treated with drug-eluting stents?
Hazard Ratio: 1.21 (95% CI 1.01–1.44)
p-value: p=0.035
High platelet reactivity is associated with an increased risk of MACCE and all-cause mortality irrespective of PCI procedural complexity.
HPR was associated with MACCE irrespective of C-PCI; leaves open whether platelet testing should guide therapy across complexities.
Complex percutaneous coronary intervention (C-PCI) and high platelet reactivity (HPR) have been proposed as representative risk factors for the high ischemic phenotype. Uncertainty remains regarding the relative prognostic importance of these factors. This study aimed to investigate the prognostic implication of HPR according to procedural complexity. Patients treated with drug-eluting stent implantation (PTRG-PFT cohort; N = 11,714) were classified according to procedural complexity. HPR criteria were determined using VerifyNow (≥252 P2Y12 reaction units). The major adverse cardiac and cerebrovascular events (MACCE) (the composite of all-cause death, myocardial infarction, definite stent thrombosis, or stroke) and major bleeding were assessed for up to 3 years. C-PCI was performed in 3,152 patients (26.9%). C-PCI significantly increased the risk of MACCE (HRadjusted: 1.21; 95% CI: 1.01-1.44; P = 0.035), driven by a higher rate of all-cause death (HRadjusted: 1.45; 95% CI: 1.15-1.83; P = 0.002), although it did not increase the risk of major bleeding. Irrespective of procedural complexity, the HPR phenotype was significantly associated with MACCE (Pinteraction = 0.731) and all-cause mortality (Pinteraction = 0.978), in which the prognostic implication appeared prominent within 1 year. The HPR phenotype did not show a significant interaction with any type of C-PCI. In addition, the number of complexity features per procedure did not proportionally increase the risk of MACCE. C-PCI was significantly associated with 3-year risk of MACCE and all-cause death. The HPR phenotype appears to have a similar prognostic implication irrespective of the type and extent of procedural complexity. (Platelet Function and Genotype-Related Long-Term Prognosis in DES-Treated Patients [PTRG-DES]; NCT04734028)
No takes yet. Share an insight, caveat, or question.
Jin et al. (2023) conducted a cohort in Patients treated with drug-eluting stent implantation (n=11,714). Complex percutaneous coronary intervention (C-PCI) vs. Non-complex PCI was evaluated on major adverse cardiac and cerebrovascular events (MACCE) (the composite of all-cause death, myocardial infarction, definite stent thrombosis, or stroke) (HR 1.21, 95% CI 1.01-1.44, p=0.035). Complex PCI significantly increased the 3-year risk of MACCE (HR 1.21; 95% CI 1.01-1.44; P=0.035), and high platelet reactivity was associated with MACCE irrespective of procedural complexity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: